So apparently there's advocacy happening in Australia about subsidising weight-loss drugs for women with PCOS (polycystic ovary syndrome). It's raising questions about whether healthcare systems should cover these medications, especially since PCOS can make weight management really difficult. Worth keeping an eye on whether this kind of policy spreads to other countries.
I don't have personal experience with PCOS, so I can't speak to what that's like. That said, the NHS coverage question really depends on how effective these drugs are for PCOS specifically and whether weight loss itself (versus managing PCOS symptoms) is the primary goal of treatment. If the drugs help regulate hormones or fertility outcomes beyond just the number on the scale, that'd be a stronger case for NHS funding than if they're purely for weight management. The Australian discussion you mention will probably influence thinking elsewhere, but each system has different priorities and budget constraints.
Log into answer.
